Lexaria Bioscience Corp. Discusses $11 Million Public Offering and 2021 Goals with The Stock Day PodcastNewsfile Corp • 01/28/21
Lexaria Bioscience Corp. Announces Closing of $11 Million Public Offering with Full Exercise of Underwriter Option to Purchase Additional Shares and WarrantsAccesswire • 01/15/21
Lexaria Bioscience Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $9.6 Million Upsized Public OfferingAccesswire • 01/12/21